Literature DB >> 32002652

Reply to: Comment on "effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis" by Cure et al.

Zoltán Szekanecz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32002652     DOI: 10.1007/s00296-020-04521-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  4 in total

1.  Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.

Authors:  Edit Végh; György Kerekes; Anita Pusztai; Attila Hamar; Szilvia Szamosi; Andrea Váncsa; Levente Bodoki; Lilla Pogácsás; Fruzsina Balázs; Katalin Hodosi; Andrea Domján; Sándor Szántó; Zoltán Nagy; Zoltán Szekanecz; Gabriella Szűcs
Journal:  Rheumatol Int       Date:  2019-12-17       Impact factor: 2.631

2.  Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the Malmö Diet and Cancer Study.

Authors:  M Rosvall; M Persson; G Östling; P M Nilsson; O Melander; B Hedblad; G Engström
Journal:  Atherosclerosis       Date:  2015-01-31       Impact factor: 5.162

3.  Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study.

Authors:  Marit Herder; Stein Harald Johnsen; Kjell Arne Arntzen; Ellisiv B Mathiesen
Journal:  Stroke       Date:  2012-05-01       Impact factor: 7.914

4.  Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk Factors.

Authors:  Agata Stanek; Armand Cholewka; Tomasz Wielkoszyński; Ewa Romuk; Karolina Sieroń; Aleksander Sieroń
Journal:  Oxid Med Cell Longev       Date:  2017-08-15       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.